Crossmark

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: combined retrospective analyses of two real-world databases and in vitro data

Crossref DOI link: https://doi.org/10.1186/s12916-025-04130-x

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niimura, Takahiro

Goda, Mitsuhiro

Nakano, Satoshi

Kajihara, Toshiki

Yahara, Koji

Hirabayashi, Aki

Miyata, Koji

Ikai, Marie

Shinohara, Motoko

Minato, Yusuke

Suzuki, Masato

Ishizawa, Keisuke
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (23H02634)

Japan Agency for Medical Research and Development (JP23gm1610013, JP23wm0325037, JP23wm0325037)

Ministry of Health, Labour and Welfare (25HA1004)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 10 December 2024

Accepted: 14 May 2025

First Online: 1 July 2025

Declarations

:

: This part of the study was approved by the Ethics Committee of Tokushima University Hospital (protocol number: 4492).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below